HCA Healthcare (NYSE:HCA – Get Rating) is scheduled to release its earnings data before the market opens on Friday, April 22nd. Analysts expect HCA Healthcare to post earnings of $4.37 per share for the quarter. HCA Healthcare has set its FY22 guidance at $18.40-19.20 EPS.Individual that are interested in registering for the company’s earnings conference call can do so using this link.
HCA Healthcare (NYSE:HCA – Get Rating) last issued its quarterly earnings data on Thursday, January 27th. The company reported $4.42 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.55 by ($0.13). HCA Healthcare had a return on equity of 303.35% and a net margin of 11.84%. The firm had revenue of $15.06 billion for the quarter, compared to analysts’ expectations of $15.41 billion. During the same period in the previous year, the business posted $4.13 EPS. The business’s revenue for the quarter was up 5.4% compared to the same quarter last year. On average, analysts expect HCA Healthcare to post $19 EPS for the current fiscal year and $20 EPS for the next fiscal year.
NYSE HCA opened at $260.94 on Friday. HCA Healthcare has a 52-week low of $190.38 and a 52-week high of $272.26. The business’s 50-day moving average price is $254.34 and its 200 day moving average price is $248.42. The firm has a market cap of $78.81 billion, a P/E ratio of 12.28, a P/E/G ratio of 1.43 and a beta of 1.60. The company has a quick ratio of 1.21, a current ratio of 1.41 and a debt-to-equity ratio of 23.06.
The business also recently declared a quarterly dividend, which was paid on Thursday, March 31st. Stockholders of record on Thursday, March 17th were given a dividend of $0.56 per share. This represents a $2.24 dividend on an annualized basis and a dividend yield of 0.86%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.48. The ex-dividend date was Wednesday, March 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.54%.
In related news, insider A Bruce Moore, Jr. sold 20,633 shares of the stock in a transaction dated Wednesday, February 16th. The shares were sold at an average price of $244.01, for a total transaction of $5,034,658.33. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Joseph A. Sowell III sold 11,522 shares of the company’s stock in a transaction dated Friday, March 11th. The stock was sold at an average price of $269.00, for a total transaction of $3,099,418.00. The disclosure for this sale can be found here. 1.50% of the stock is owned by corporate insiders.
A number of hedge funds and other institutional investors have recently bought and sold shares of HCA. Penserra Capital Management LLC boosted its holdings in shares of HCA Healthcare by 16.8% in the fourth quarter. Penserra Capital Management LLC now owns 1,114 shares of the company’s stock valued at $286,000 after acquiring an additional 160 shares in the last quarter. Glenmede Trust Co. NA boosted its holdings in shares of HCA Healthcare by 27.6% in the fourth quarter. Glenmede Trust Co. NA now owns 1,324 shares of the company’s stock valued at $340,000 after acquiring an additional 286 shares in the last quarter. NEXT Financial Group Inc boosted its holdings in shares of HCA Healthcare by 48.9% in the fourth quarter. NEXT Financial Group Inc now owns 1,802 shares of the company’s stock valued at $463,000 after acquiring an additional 592 shares in the last quarter. Colony Group LLC boosted its holdings in shares of HCA Healthcare by 25.7% in the fourth quarter. Colony Group LLC now owns 2,331 shares of the company’s stock valued at $599,000 after acquiring an additional 477 shares in the last quarter. Finally, 1832 Asset Management L.P. boosted its holdings in shares of HCA Healthcare by 79.6% in the fourth quarter. 1832 Asset Management L.P. now owns 3,395 shares of the company’s stock valued at $885,000 after acquiring an additional 1,505 shares in the last quarter. Hedge funds and other institutional investors own 66.36% of the company’s stock.
Several research analysts recently issued reports on the company. Truist Financial lifted their price objective on HCA Healthcare from $290.00 to $310.00 and gave the stock a “buy” rating in a research report on Wednesday, January 5th. Mizuho boosted their price target on HCA Healthcare from $275.00 to $290.00 and gave the company a “buy” rating in a report on Monday, December 20th. SVB Leerink cut their price target on HCA Healthcare from $320.00 to $304.00 and set an “outperform” rating for the company in a report on Friday, January 28th. JPMorgan Chase & Co. cut shares of HCA Healthcare from an “overweight” rating to a “neutral” rating and set a $270.00 price objective for the company. in a research note on Tuesday, December 21st. Finally, Wells Fargo & Company initiated coverage on shares of HCA Healthcare in a research note on Monday, March 28th. They set an “equal weight” rating and a $267.00 price objective for the company. Eight research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $279.55.
HCA Healthcare Company Profile (Get Rating)
HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
- Get a free copy of the StockNews.com research report on HCA Healthcare (HCA)
- Lululemon Rises On Wave Of Price Target Increases
- 3 Stellar Steel Stocks to Buy Now
- Is Nvidia (NASDAQ: NVDA) About To Rip Higher?
- The Top Is In For Infosys
- Bed Bath & Beyond Uncovers The Problem With Q1 Earnings Season
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.